Global Footprint Inomed operates through 11 subsidiaries with a global distributor network spanning more than 100 countries, serving over 5,000 hospitals and enabling around 500,000 procedures annually. This broad reach creates immediate opportunities to expand intraoperative neuromonitoring adoption in hospitals and surgical centers that currently rely on competitors, supported by localized training and bundled offerings.

Cross Sell Opportunities With three business areas Intraoperative Neuromonitoring, Functional Neurosurgery, and Pain Treatment, there is strong potential to cross sell from installed neuromonitoring equipment into complementary surgical solutions. Propose bundled packages, integrated operating room workflows, and joint training to increase customer lifetime value and simplify procurement for hospital systems.

Channel Partnership Momentum Recent partnerships with Endopersonalcare and Endotherapeutics show momentum for co selling and portfolio expansion. There is an opportunity to formalize regional partner programs, co marketing, and distributor enablement to accelerate neuromonitoring adoption in the OHNS segment and beyond.

Service Revenue Potential With a reported revenue range of 100 to 250 million and a substantial installed base, there is clear potential to grow recurring revenue through service contracts, extended warranties, spare parts, and ongoing training. Positioning these offerings as essential to patient safety and uptime in busy operating rooms can drive higher attach rates and steady revenue growth.

OHNS Market Targeting Target hospitals and hospital groups in need of comprehensive neuromonitoring solutions, particularly in OHNS and functional neurosurgery, by mapping procurement pathways, GPOs, and regional tenders. Leverage the global footprint and distributor network to land pilots, case studies, and rapid ROI demonstrations that shorten sales cycles.